Choosing the right patients for FreeStyle Libre systems doesn’t have to be complicated. Help your patients make real progress today.
FreeStyle Libre systems are for all people living with diabetes*. Empower your patients with diabetes management that can lead to better outcomes†1-3.
This includes (but is not limited to) your patients who:
Face the burden of frequent blood glucose monitoring4
Risk possible hypoglycemia or high glucose excursions5
See the guidelines from the American Diabetes Association to learn more.
Here’s what to consider when selecting patients who can benefit from CGM with FreeStyle Libre systems.
1. Make a diagnosis6:
2. Note any clinical considerations6 that apply to your patient:
3. Consider cost and coverage options for your patient, including:
How Debra§ increased her TIR to 87% and reduced diabetes burden
Learn how her CGM uncovered key insights, enabling Debra§ and her doctor to action a plan together to get her glucose levels under control.
How Marco§ became an active partner in his glucose management
In just four months, Marco§ was able to achieve 99% TIR and experienced even more health benefits using the FreeStyle Libre 2 system7.
TIR = Time in Range; CGM = continuous glucose monitoring
This quick survey will help us strengthen this training. We appreciate your feedback!
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
* FreeStyle Libre 2 and FreeStyle Libre 3 systems are indicated for use in people with diabetes age 4 and older.
† Data from these studies were collected with the outside US version of FreeStyle Libre 14-day system. FreeStyle Libre 2 and FreeStyle Libre 3 have the same features as FreeStyle Libre 14-day system with optional, real-time glucose alarms. Therefore, the study data is applicable to all products.
‡ Default range is 70-180 mg/dL. Consult with a healthcare professional on individual target glucose range.
§ Actual patient information, although not the patient’s real name or image.
References: 1. Fokkert, M. BMJ Open Diabetes Research & Care (2019). https://doi.org/10.1136/bmjdrc-2019-000809. 2. Haak, T. Diabetes Therapy (2017). https://doi.org/10.1007/s13300-016-0223-6. 3. Campbell, F. Pediatric Diabetes (2018). https://doi.org/10.1111/pedi.12735. 4. American Diabetes Association. “7. Diabetes Technology.” Standards of Care in Diabetes (2023). Diabetes Care 2023;46(Suppl. 1):S111-127. https://doi.org/10.2337/dc23-S007. 5. Ajjan, R; Slattery, D; Wright, E. “Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.” Adv Ther (2019) 36:579-96. https://doi.org/10.1007/s12325-019-0870-x. 6. Association of Diabetes Care & Education Specialists. “Personal Continuous Glucose Monitoring Implementation Playbook.” 2020. https://www.adces.org/docs/default-source/cgm-playbook-worksheets/ws9016ad04b-befc-4b28-bb1a-59a541f99087.pdf?sfvrsn=816b6859_6. Accessed April 15, 2024. 7. Data on file. Abbott Diabetes Care, Inc.
ADC-83482 v1.0
Important Safety Information
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v19.0
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
